SteadySharesSteadyShares
Try now

Cryoport, Inc. (CYRX)

Industrials · NCM

$17.55+1.33% today

Price as at 30 Sept 2026, 17:26 UTC. Quotes are delayed.

Fundamentals

Market cap$832.14M
Revenue growth (YoY)+16.5%
Profit margin43.6%
Return on equity-8.2%
52-week range$7.61 to $17.98

Valuation and ratings

Fair value estimate$8.98
Upside to fair value-48.8%
Analyst target (mean)$15.61
Analyst range$12.00 to $20.00
Analysts with price targets9
Consensus viewnone
Moat score60/100
Overall rating29/100, very low quality

Fair value: $8.98 (-48.8%), see how we got there

Cryoport, Inc. trades at $17.55, which is 49% above the $8.98 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.

Our moat model scores it 60 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

CYRX earnings and analyst estimates

EPS estimate, next year-$0.62
Expected EPS growth+15.4%
Expected revenue growth+9.6%

Recommendation mix, 9 published ratings

8 buy1 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Cryoport, Inc.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Industry: Integrated Freight & LogisticsEmployees: 684HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

CYRX passes 1 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Aerospace and defence
Governments are rearming and the order books run for a decade. The customer cannot stop buying, and it also sets your margin.

Super investor ownership

9 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in CYRX

We hold 17 disclosed trades in CYRX by members of Congress and executive-branch officials. The latest 5:

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

CYRX peers

The largest companies in the same industry (Integrated Freight & Logistics), then in the same sector.

Every industrials company we cover is on the Industrials hub.

Common questions

Is Cryoport, Inc. (CYRX) undervalued?

Against our fair value estimate of $8.98, CYRX at $17.55 is 49% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Which funds own CYRX?

9 of the institutions we track reported a position in CYRX in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.

Where does SteadyShares get its CYRX data?

Fundamentals for CYRX come from company filings and exchange data, as listed on NCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 17:26 UTC and is delayed. Our data quality score for this company is 83/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for CYRX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Open CYRX in the appFree guides and screens

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.